Vildaglit

Vildaglit

vildagliptin

Manufacturer:

Healthcare Pharma

Distributor:

San Lwin Trading

Marketer:

San Lwin Trading
Concise Prescribing Info
Contents
Vildagliptin
Indications/Uses
Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM as monotherapy or in dual combination w/ metformin, sulphonylurea, thiazolidinedione or insulin when diet, exercise & a single antidiabetic agent do not result in adequate glycaemic control.
Dosage/Direction for Use
Monotherapy 50 or 100 mg daily. In dual combination w/ metformin or thiazolidinedione 50 mg bd (morning & evening). In dual combination w/ sulphonylurea 50 mg once daily in the morning.
Administration
May be taken with or without food.
Special Precautions
Discontinue if acute pancreatitis symptoms (persistent, severe abdominal pain) occur. Monitor liver function. Heart failure; avoid in moderate or severe. Pregnancy. Not to be used during lactation. Not recommended in childn <18 yr.
Adverse Reactions
Nausea, peripheral oedema, headache, tremor, asthenia, dizziness; constipation, hypoglycaemia, arthralgia.
Drug Interactions
Glucose-lowering effect may be reduced by thiazides, corticosteroids, thyroid products & sympathomimetics.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BH02 - vildagliptin ; Belongs to the class of dipeptidyl peptidase 4 (DPP-4) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Vildaglit tab 50 mg
Packing/Price
2 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in